documents: FDA-2002-P-0213-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2002-P-0213-0002 | FDA | FDA-2002-P-0213 | Letter from FDA CBER to Biogen, Inc. | Other | LET-Letter | 2002-10-10T04:00:00Z | 2002 | 10 | 2024-08-13T13:48:09Z | 0 | 0 | 0900006480496906 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref